Trial · NCT00073021
Outcomes12
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
1 to 12 of 12
Download this page as JSON| Type | Outcome | Time frame | Population | Units | Measured as |
|---|---|---|---|---|---|
| PRIMARY | Percentage of Treatment Success Patients at Week 6, ITT (Intent to Treat) Population | 6 Weeks | ITT Population with Moderate Disease \[PGA = 2\] at Baseline | Percentage of Participants | NUMBER |
| SECONDARY | Change From Baseline in Ulcerative Colitis Disease Activity Index (UCDAI) at Week 6, ITT Population | 6 weeks | ITT Population with Moderate Disease \[PGA = 2\] at Baseline. | Scores on a Scale | MEAN |
| SECONDARY | Percentage of Participants Whose Rectal Bleeding & Sigmoidoscopy Score Both Improved From Baseline to Week 6, ITT Population | 6 Weeks | ITT Patients with Moderate Disease \[PGA=2\] at Baseline. Percentage of patients whose rectal bleeding AND sigmoidoscopy scores BOTH improved from baseline at Week 6 | Percentage of Participants | NUMBER |
| SECONDARY | Percentage of Patients Whose Sigmoidoscopy Score Improved From Baseline to Week 6, ITT Population | 6 Weeks | ITT Population with Moderate Disease \[PGA=2\] at Baseline | Percentage of Participants | NUMBER |
| SECONDARY | Percentage of Patients With an Improvement in Stool Frequency, ITT Population, Week 6 | 6 Weeks | ITT Patients with Moderate Disease \[PGA=2\] at Baseline | Percentage of Participants | NUMBER |
| SECONDARY | Percentage of Patients With Improvement in Rectal Bleeding, ITT Population, Week 6 | 6 Weeks | ITT Population with Moderate Disease \[PGA=2\] at Baseline | Percentage of Participants | NUMBER |
| SECONDARY | Percentage of Patients With Improvement in Patient's Functional Assessment (PFA), ITT Population, Week 6 | 6 Weeks | ITT Population with Moderate Disease \[PGA=2\] at Baseline | Percentage of Participants | NUMBER |
| SECONDARY | Percentage of Patients With Improvement in Physician Global Assessment (PGA)Score, ITT Population, Week 6 | 6 Weeks | ITT Population with Moderate Disease \[PGA=2\] at Baseline | Percentage of Participants | NUMBER |
| SECONDARY | Mean Change From Baseline in Total Inflammatory Bowel Disease Questionnaire (IBDQ) at Week 3, All Randomized Patients | 3 Weeks | All Randomized Patients with Moderate Disease\[PGA=2\] at Baseline. Questionnaire analyzable if patient answered 28 of 32 for total, 8/10 for bowel, 3/5 for systemic, 10/12 for emotional, 3/5 for social. | Scores on a Scale | MEAN |
| SECONDARY | Mean Change From Baseline in Total Inflammatory Bowel Disease Questionnaire (IBDQ) at Week 6, All Randomized Patients | 6 Weeks | All Randomized Patients with Moderate Disease \[PGA=2\] at Baseline. Questionnaire analyzable if patient answered 28 of 32 for total, 8/10 for bowel, 3/5 for systemic, 10/12 for emotional, 3/5 for social. | Scores on a Scale | MEAN |
| SECONDARY | Percentage of Patients With Moderate, Left-Sided Disease at Baseline Classified as Treatment Success at Week 6, All Randomized Patients | 6 Weeks | All Randomized Patients with Moderate Disease \[PGA=2\] at Baseline. Left Sided Disease = proctitis, proctosigmoiditis or left-sided colitis | Percentage of Participants | NUMBER |
| SECONDARY | Percentage of Treatment Success Patients at Week 3, ITT Population | 3 Weeks | ITT Patients with Moderate Disease \[PGA = 2\] at Baseline | Percentage of Participants | NUMBER |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT00073021/outcomes